You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 246 No. 16, October 16, 1981 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (141)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Penicillin V for Group A Streptococcal Pharyngotonsillitis

A Randomized Trial of Seven vs Ten Days' Therapy

Richard H. Schwartz, MD; Raoul L. Wientzen, Jr, MD; Frank Pedreira, MD; Edward J. Feroli, MD; Gordon W. Mella, MD; Vincent L. Guandolo, MD

JAMA. 1981;246(16):1790-1795.


Abstract

The effect of duration of orally administered penicillin V potassium on the bacteriologic and clinical cure of group A streptococcal pharyngitis was evaluated. One hundred ninety-one middle-class patients received either seven days (96 patients) or ten days (95 patients) of therapy. Compliance with taking penicillin was assessed by multiple methods, including penicillinuria. Throat cultures were obtained during therapy and three times in the three weeks after therapy. M-precipitin and T-agglutinin typing were done on paired isolates of group A streptococci from patients who had recurrences. Patients treated for seven days had a significantly greater failure rate (30/96 [31%]) compared with patients receiving ten days of penicillin (17/95 [18%]). Compliance rates were high; 66% to 81% of patients showed penicillinuria throughout the study period. Treatment failure was not a function of poor compliance in either treatment group. The data support the current recommendation for ten full days of penicillin therapy and suggest that persistence of streptococci in the throat after adequate therapy may be common.

(JAMA 1981;246:1790-1795)



Author Affiliations

From the Departments of Pediatrics, Georgetown University School of Medicine (Drs Schwartz and Wientzen) and George Washington University (Drs Pedreira, Feroli, Mella, and Guandolo), Washington, DC.


Footnotes

Reprint requests to Room 130 Gorman, Georgetown University Hospital, 3800 Reservoir Rd NW, Washington, DC 20007 (Dr Wientzen).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effectiveness and Safety of Short-Course vs Long-Course Antibiotic Therapy for Group A {beta}-Hemolytic Streptococcal Tonsillopharyngitis: A Meta-analysis of Randomized Trials
Falagas et al.
Mayo Clin Proc. 2008;83:880-889.
ABSTRACT | FULL TEXT  

Pharmacodynamic Analysis and Clinical Trial of Amoxicillin Sprinkle Administered Once Daily for 7 Days Compared to Penicillin V Potassium Administered Four Times Daily for 10 Days in the Treatment of Tonsillopharyngitis Due to Streptococcus pyogenes in Children
Pichichero et al.
Antimicrob. Agents Chemother. 2008;52:2512-2520.
ABSTRACT | FULL TEXT  

How Do You Improve Compliance?
Winnick et al.
Pediatrics 2005;115:e718-e724.
ABSTRACT | FULL TEXT  

Short-Course Antimicrobial Therapy of Streptococcal Pharyngitis
Block
CLIN PEDIATR 2003;42:663-671.
 

Efficacy of Penicillin vs. Amoxicillin in Children with Group A Beta Hemolytic Streptococcal Tonsillopharyngitis
Curtin-Wirt et al.
CLIN PEDIATR 2003;42:219-225.
ABSTRACT  

Five day clarithromycin modified release versus 10 day penicillin V for group A streptococcal pharyngitis: a multi-centre, open-label, randomized study
Portier et al.
J Antimicrob Chemother 2002;49:337-344.
ABSTRACT | FULL TEXT  

Acute Pharyngitis
Bisno
NEJM 2001;344:205-211.
FULL TEXT  

The Impact of Dosing Frequency on the Efficacy of 10-Day Penicillin or Amoxicillin Therapy for Streptococcal Tonsillopharyngitis: A Meta-analysis
Lan et al.
Pediatrics 2000;105:19e-19.
ABSTRACT | FULL TEXT  

Penicillin for acute sore throat: randomised double blind trial of seven days versus three days treatment or placebo in adults
Zwart et al.
BMJ 2000;320:150-154.
ABSTRACT | FULL TEXT  

Pharyngitis---Principles of Judicious Use of Antimicrobial Agents
Schwartz et al.
Pediatrics 1998;101:171-174.
ABSTRACT | FULL TEXT  

Diagnosis and treatment of streptococcal sore throat
DTB 1995;33:9-12.
ABSTRACT | FULL TEXT  

Effective Short-Course Treatment of Acute Group A {beta}-Hemolytic Streptococcal Tonsillopharyngitis: Ten Days of Penicillin V vs 5 Days or 10 Days of Cefpodoxime Therapy in Children
Pichichero et al.
Arch Pediatr Adolesc Med 1994;148:1053-1060.
ABSTRACT  

Explanations and Therapies for Penicillin Failure in Streptococcal Pharyngitis
Pichichero
CLIN PEDIATR 1992;31:642-649.
ABSTRACT  

Cephalexin and Penicillin in the Treatment of Group A {beta}-Hemolytic Streptococcal Throat Infections
Disney et al.
Arch Pediatr Adolesc Med 1992;146:1324-1327.
ABSTRACT  

Optimal Dosing Interval for Penicillin Treatment of Streptococcal Pharyngitis
Krober et al.
CLIN PEDIATR 1990;29:646-648.
ABSTRACT  

Is Standard Practice 'Standard' In Community Pediatrics?
PRESTON
Arch Pediatr Adolesc Med 1990;144:12-13.
ABSTRACT  

Five vs Ten Days of Penicillin V Therapy for Streptococcal Pharyngitis
Gerber et al.
Arch Pediatr Adolesc Med 1987;141:224-227.
ABSTRACT  

Treatment of Streptococcal Pharyngitis Revisited
Bass
JAMA 1986;256:740-743.
ABSTRACT  

Group G Streptococcal Pharyngitis: Analysis of an Outbreak at a College
McCue
JAMA 1982;248:1333-1336.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.